327 related articles for article (PubMed ID: 10717614)
1. Patterns of practice survey for nonsmall cell lung carcinoma in the U.S.
Choy H; Shyr Y; Cmelak AJ; Mohr PJ; Johnson DH
Cancer; 2000 Mar; 88(6):1336-46. PubMed ID: 10717614
[TBL] [Abstract][Full Text] [Related]
2. Approach to the non-operative management of patients with stage II non-small cell lung cancer (NSCLC): A survey of Canadian medical and radiation oncologists.
Dudani S; Leighl NB; Ho C; Pantarotto JR; Zhu X; Zhang T; Wheatley-Price P
Lung Cancer; 2016 Apr; 94():74-80. PubMed ID: 26973210
[TBL] [Abstract][Full Text] [Related]
3. Bladder-Preserving Therapy Patterns of Care: A Survey of US Radiation Oncologists.
Solanki AA; Martin B; Korpics M; Small C; Harkenrider MM; Mitin T
Int J Radiat Oncol Biol Phys; 2017 Oct; 99(2):383-387. PubMed ID: 28871988
[TBL] [Abstract][Full Text] [Related]
4. Paclitaxel and carboplatin adjuvant therapy alone or with radiotherapy for resected nonsmall cell lung carcinoma: a feasibility study of the Minnie Pearl Cancer Research Network.
Greco FA; Burris HA; Gray JR; Raefsky EL; Dobbs C; Smith S; Rinaldi D; Morrissey LH; Erland JB; Litchy S; Hainsworth JD
Cancer; 2001 Oct; 92(8):2142-7. PubMed ID: 11596031
[TBL] [Abstract][Full Text] [Related]
5. Use of adjuvant chemotherapy (CT) and radiotherapy (RT) in incompletely resected (R1) early stage Non-Small Cell Lung Cancer (NSCLC): a European survey conducted by the European Society for Medical Oncology (ESMO) young oncologists committee.
Califano R; Karamouzis MV; Banerjee S; de Azambuja E; Guarneri V; Hutka M; Jordan K; Kamposioras K; Martinelli E; Corral J; Postel-Vinay S; Preusser M; Porcu L; Torri V
Lung Cancer; 2014 Jul; 85(1):74-80. PubMed ID: 24746176
[TBL] [Abstract][Full Text] [Related]
6. Timing of Thoracic Radiation Therapy With Chemotherapy in Limited-stage Small-cell Lung Cancer: Survey of US Radiation Oncologists on Current Practice Patterns.
Farrell MJ; Yahya JB; Degnin C; Chen Y; Holland JM; Henderson MA; Jaboin JJ; Harkenrider MM; Thomas CR; Mitin T
Clin Lung Cancer; 2018 Nov; 19(6):e815-e821. PubMed ID: 29857969
[TBL] [Abstract][Full Text] [Related]
7. Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study.
Bradley JD; Paulus R; Komaki R; Masters G; Blumenschein G; Schild S; Bogart J; Hu C; Forster K; Magliocco A; Kavadi V; Garces YI; Narayan S; Iyengar P; Robinson C; Wynn RB; Koprowski C; Meng J; Beitler J; Gaur R; Curran W; Choy H
Lancet Oncol; 2015 Feb; 16(2):187-99. PubMed ID: 25601342
[TBL] [Abstract][Full Text] [Related]
8. [Current data concerning neoadjuvant chemotherapy].
Depierre A
Rev Pneumol Clin; 2006 Feb; 62 Spec no 1():1S11-3. PubMed ID: 16719148
[No Abstract] [Full Text] [Related]
9. Treatment Patterns and Health Resource Utilization Among Patients Diagnosed With Early Stage Resected Non-Small Cell Lung Cancer at US Community Oncology Practices.
Buck PO; Saverno KR; Miller PJ; Arondekar B; Walker MS
Clin Lung Cancer; 2015 Nov; 16(6):486-95. PubMed ID: 25681298
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of cisplatin, carboplatin, and etoposide in metastatic nonsmall cell lung carcinoma. A phase II study of the Southwest Oncology Group.
Figlin RA; Crowley JJ; Jacobs EL; Muirhead M; Goodwin JW; Rinehart JJ; Livingston RB
Cancer; 1996 Sep; 78(5):998-1003. PubMed ID: 8780537
[TBL] [Abstract][Full Text] [Related]
11. Patterns of disease failure after trimodality therapy of nonsmall cell lung carcinoma pathologic stage IIIA (N2). Analysis of Cancer and Leukemia Group B Protocol 8935.
Kumar P; Herndon J; Langer M; Kohman LJ; Elias AD; Kass FC; Eaton WL; Seagren SL; Green MR; Sugarbaker DJ
Cancer; 1996 Jun; 77(11):2393-9. PubMed ID: 8635112
[TBL] [Abstract][Full Text] [Related]
12. [Medical treatment for stage III non-small-cell lung cancer (NSCLC)].
Okamoto H; Watanabe K
Gan To Kagaku Ryoho; 2007 Jun; 34(6):841-8. PubMed ID: 17565244
[TBL] [Abstract][Full Text] [Related]
13. Irinotecan-cisplatin therapy for patients with extensive-stage small cell lung cancer: use patterns among American medical oncologists 2000-2006.
Green MR; Dowlati A; Yellamraju L; Daniels L; Willey J; Andrews M; Leff R
J Thorac Oncol; 2007 Oct; 2(10):953-6. PubMed ID: 17909359
[TBL] [Abstract][Full Text] [Related]
14. Randomized phase II study of concurrent cisplatin/etoposide or paclitaxel/carboplatin and thoracic radiotherapy in patients with stage III non-small cell lung cancer.
Wang L; Wu S; Ou G; Bi N; Li W; Ren H; Cao J; Liang J; Li J; Zhou Z; Lv J; Zhang X
Lung Cancer; 2012 Jul; 77(1):89-96. PubMed ID: 22418243
[TBL] [Abstract][Full Text] [Related]
15. Treatment of advanced (stages III and IV) non-small-cell lung cancer.
Sweeney CJ; Sandler AB
Curr Probl Cancer; 1998; 22(2):85-132. PubMed ID: 9580849
[TBL] [Abstract][Full Text] [Related]
16. Two commonly used neoadjuvant chemoradiotherapy regimens for locally advanced stage III non-small cell lung carcinoma: long-term results and associations with pathologic response.
Machtay M; Lee JH; Stevenson JP; Shrager JB; Algazy KM; Treat J; Kaiser LR
J Thorac Cardiovasc Surg; 2004 Jan; 127(1):108-13. PubMed ID: 14752420
[TBL] [Abstract][Full Text] [Related]
17. [The results of combined treatment for stage III lung cancer including the use of intraoperative radiotherapy].
Dobrodeev AIu; Zav'ialov AA; Tyzikov SA; Musabaeva LI
Vopr Onkol; 2013; 59(5):606-10. PubMed ID: 24260889
[TBL] [Abstract][Full Text] [Related]
18. A randomized trial of postoperative adjuvant therapy in patients with completely resected stage II or IIIA non-small-cell lung cancer. Eastern Cooperative Oncology Group.
Keller SM; Adak S; Wagner H; Herskovic A; Komaki R; Brooks BJ; Perry MC; Livingston RB; Johnson DH
N Engl J Med; 2000 Oct; 343(17):1217-22. PubMed ID: 11071672
[TBL] [Abstract][Full Text] [Related]
19. Clinical presentation of stage IIIA (N2) non-small cell lung cancer: role of multimodality therapy.
Friedberg JS
Chest; 1999 Dec; 116(6 Suppl):497S-499S. PubMed ID: 10619518
[TBL] [Abstract][Full Text] [Related]
20. Underutilization of the CROSS Regimen Among US Radiation Oncologists: A National Survey of Practice Patterns.
Elliott DA; Rana SR; Nabavizadeh N; Chen Y; Kusano A; Holland JM; Mitin T
Anticancer Res; 2018 Nov; 38(11):6375-6379. PubMed ID: 30396960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
